In vivo corneal confocal microscopy and prediction of future-incident neuropathy in type 1 diabetes: a preliminary longitudinal analysis.

OBJECTIVE In vivo corneal confocal microscopy (IVCCM) has been established in cross-sectional studies as a valid measure for the identification of diabetic sensorimotor polyneuropathy (DSP). We aimed to determine the predictive validity of a baseline IVCCM measure in identifying future DSP onset in patients with type 1 diabetes. METHODS We followed 65 patients with type 1 diabetes without DSP at baseline. They were followed longitudinally for a mean of 3.5±0.9 years and underwent IVCCM, clinical and electrophysiologic examinations at baseline and follow up. At the end of follow up, participants were assigned as new-onset cases of DSP or as controls. Predictive validity was assessed using receiver operating characteristic curves. RESULTS At baseline, participants were 34±15 years of age with mean diabetes duration of 18±12 years. The 11 (17%) new-onset cases of DSP were similar to the 54 (83%) controls in baseline age, diabetes duration, gender, glycated hemoglobin levels and electrophysiologic parameters (p≥0.20). However, cases of new onset had significantly lower baseline corneal nerve fibre length (CNFL) and branch density (p<0.05). For identification of new-onset cases, area under the receiver operating characteristic curve for CNFL was 0.78 with an optimal threshold of 14.9 mm/mm(2) (sensitivity=0.82, specificity=0.69). CONCLUSIONS Despite similar clinical and electrophysiologic parameters, participants with type 1 diabetes at risk for future DSP had significantly lower baseline IVCCM measures. CNFL may have applicability in identifying high-risk patients for therapeutic intervention in clinical research and practice.

[1]  J. Lupski,et al.  Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review) , 2009, Neurology.

[2]  The impact of common variation in the definition of diabetic sensorimotor polyneuropathy on the validity of corneal in vivo confocal microscopy in patients with type 1 diabetes: a brief report. , 2013, Journal of diabetes and its complications.

[3]  M. Horowitz,et al.  Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments(Diabetes Care (2010) 33, (2285-2293)) , 2010 .

[4]  J. Albers,et al.  Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications , 2012, Diabetic medicine : a journal of the British Diabetic Association.

[5]  P. Thomas,et al.  Classification, Differential Diagnosis, and Staging of Diabetic Peripheral Neuropathy , 1997, Diabetes.

[6]  Nathan Efron,et al.  Corneal Confocal Microscopy , 2010, Diabetes Care.

[7]  P. Scuffham,et al.  The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S. , 2003 .

[8]  Rayaz A. Malik,et al.  Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments , 2010, Diabetes Care.

[9]  L. Dušek,et al.  Prediabetes/early diabetes‐associated neuropathy predominantly involves sensory small fibres , 2012, Journal of the peripheral nervous system : JPNS.

[10]  K. Digre,et al.  Corneal confocal microscopy is efficient, well‐tolerated, and reproducible , 2013, Journal of the peripheral nervous system : JPNS.

[11]  E. Feldman,et al.  The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy , 2008, Journal of the peripheral nervous system : JPNS.

[12]  M. Stewart,et al.  Diabetes Management in Canada: Baseline Results of the Group Practice Diabetes Management Study , 2006 .

[13]  J. Lupski,et al.  Practice Parameter: The Evaluation of Distal Symmetric Polyneuropathy: The Role of Autonomic Testing, Nerve Biopsy, and Skin Biopsy (An Evidence‐Based Review) , 2009, PM & R : the journal of injury, function, and rehabilitation.

[14]  A. Orszag,et al.  Prediction of Incident Diabetic Neuropathy Using the Monofilament Examination , 2010, Diabetes Care.

[15]  W. Litchy,et al.  Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial , 2010, Muscle & nerve.

[16]  Shin J. Oh.  Clinical Electromyography: Nerve Conduction Studies , 1984 .

[17]  Elise M. Halpern,et al.  Structure-Function Relationship Between Corneal Nerves and Conventional Small-Fiber Tests in Type 1 Diabetes , 2013, Diabetes Care.

[18]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[19]  D. Ziegler,et al.  Clinical trials for drugs against diabetic neuropathy: can we combine scientific needs with clinical practicalities? , 2002, International review of neurobiology.

[20]  A. Orszag,et al.  Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[21]  L. E. Lovblom,et al.  Higher magnification lenses versus conventional lenses for evaluation of diabetic neuropathy by corneal in vivo confocal microscopy. , 2012, Diabetes research and clinical practice.

[22]  J. Shaw,et al.  Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? , 2002, Diabetes care.

[23]  A. Orszag,et al.  Heart Rate Variability and Sensorimotor Polyneuropathy in Type 1 Diabetes , 2012, Diabetes Care.

[24]  Xin Chen,et al.  Repeatability of In Vivo Corneal Confocal Microscopy to Quantify Corneal Nerve Morphology , 2013, Cornea.

[25]  M. Roden,et al.  Early Detection of Nerve Fiber Loss by Corneal Confocal Microscopy and Skin Biopsy in Recently Diagnosed Type 2 Diabetes , 2014, Diabetes.

[26]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[27]  G. Gronseth,et al.  Distal symmetric polyneuropathy: A definition for clinical research , 2005, Neurology.

[28]  J. Singleton,et al.  Impaired Glucose Tolerance and Neuropathy , 2008, The neurologist.

[29]  A. Boulton,et al.  Corneal Nerve Loss Detected With Corneal Confocal Microscopy Is Symmetrical and Related to the Severity of Diabetic Polyneuropathy , 2013, Diabetes Care.

[30]  Nish Chaturvedi,et al.  Vascular risk factors and diabetic neuropathy. , 2005, The New England journal of medicine.

[31]  A. Vinik,et al.  Neuropathy in prediabetes: does the clock start ticking early? , 2011, Nature Reviews Endocrinology.

[32]  C. Sumner,et al.  The spectrum of neuropathy in diabetes and impaired glucose tolerance , 2003, Neurology.

[33]  A. Orszag,et al.  Diabetic Neuropathy and Axon Reflex-Mediated Neurogenic Vasodilatation in Type 1 Diabetes , 2012, PloS one.

[34]  N. Pritchard,et al.  Natural history of corneal nerve morphology in mild neuropathy associated with type 1 diabetes: development of a potential measure of diabetic peripheral neuropathy. , 2014, Investigative ophthalmology & visual science.

[35]  B. Perkins,et al.  Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. , 2002, Diabetes care.

[36]  Nathan Efron,et al.  Corneal Confocal Microscopy Predicts 4-Year Incident Peripheral Neuropathy in Type 1 Diabetes , 2015, Diabetes Care.

[37]  L. E. Lovblom,et al.  Does the Prevailing Hypothesis That Small-Fiber Dysfunction Precedes Large-Fiber Dysfunction Apply to Type 1 Diabetic Patients? , 2014, Diabetes Care.

[38]  Elise M. Halpern,et al.  Identification and Prediction of Diabetic Sensorimotor Polyneuropathy Using Individual and Simple Combinations of Nerve Conduction Study Parameters , 2013, PloS one.

[39]  N. Pritchard,et al.  Utility of corneal confocal microscopy for assessing mild diabetic neuropathy: baseline findings of the LANDMark study , 2012, Clinical & experimental optometry.

[40]  J. Graham,et al.  Repeatability of Measuring Corneal Subbasal Nerve Fiber Length in Individuals With Type 2 Diabetes , 2010, Eye & contact lens.

[41]  E. Stålberg,et al.  Early diabetic neuropathy: thermal thresholds and intraepidermal nerve fibre density in patients with normal nerve conduction studies , 2008, Journal of Neurology.

[42]  P. Scuffham,et al.  The health care costs of diabetic peripheral neuropathy in the US. , 2003, Diabetes care.

[43]  Steven Orlov,et al.  Detection of Diabetic Sensorimotor Polyneuropathy by Corneal Confocal Microscopy in Type 1 Diabetes , 2012, Diabetes Care.

[44]  Nathan Efron,et al.  Longitudinal assessment of neuropathy in type 1 diabetes using novel ophthalmic markers (LANDMark): study design and baseline characteristics. , 2014, Diabetes research and clinical practice.

[45]  G. Gronseth,et al.  Distal symmetrical polyneuropathy: Definition for clinical research , 2005, Muscle & nerve.